about
Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts.Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac.Current status and future direction in the management of malignant melanoma.Synthesis of MR-49, a deiodinated analog of tetraiodothyroacetic acid (tetrac), as a novel pro-angiogenesis modulator.Hepatitis C virus management: potential impact of nanotechnology.Targeted delivery of cisplatin to tumor xenografts via the nanoparticle component of nano-diamino-tetrac.Prognostic value of some inflammatory markers in patients with lymphomaNovel Targeted Nano-Parthenolide Molecule against NF-kB in Acute Myeloid Leukemia
P50
Q33627880-21C7F0C2-4688-437A-87CE-212CCBBDFC80Q37628931-F993EC3E-8C3D-459C-AFC8-0F74D35E110FQ37652873-8C377900-73B9-4A2F-9FA7-AA26BC48B6DFQ38643805-D844C0B8-8DC2-4082-B526-770365F06121Q38759734-3A2E6987-5929-409B-BC9F-12C0EF4F4AE1Q39278958-BBEBED68-89EF-43A4-BCE6-1113814D9541Q52800940-7DDD7423-CB8F-4DA2-BAEF-B20024F1C4EEQ64073805-EC1BA304-C44B-4ADB-A77E-D9BB7F9A3538Q92519602-0701140B-E848-468C-944F-E64684E77EF1
P50
description
researcher
@en
name
Noureldien H E Darwish
@en
type
label
Noureldien H E Darwish
@en
prefLabel
Noureldien H E Darwish
@en
P31
P496
0000-0002-4124-9772